MOLECULAR PATHOLOGY IN DISEASE PROGRESSION: INTEGRATING GENOMIC BIOMARKERS FOR PRECISION DIAGNOSIS

Abstract

The Integration of genomic and proteomic markers into diagnostics systems has made molecular pathology a key tool for understanding the development of diseases. The objective of this research study was to explore the disease associated molecular changes via an integrative multi-omics study involving gene expression, protein expression and clinical data of an existing breast cancer dataset. Using differential expression analysis, key genes that are involved in the disease progression were identified, and using the protein-level analysis, alterations in signaling pathways were identified. Molecular profiling revealed important relationships between molecular characteristics and clinical data, which were further confirmed by integrative analysis, allowing the identification of robust genomic markers. The functional enrichment and pathway analysis showed involvement of critical biological processes, such as cell proliferation, apoptosis and signal transduction pathways. Furthermore, network analysis found hub genes that had a high centrality, indicating that they could be used as diagnostic and therapeutic targets. The results highlight the need for multi-omics data fusion and computational tools to gain better insights into the disease pathology at a molecular level. This research offers a comprehensive blueprint for incorporating genomic biomarkers into precision diagnostics, aiding in the development of personalized medicine and better clinical decision-making.